Cargando…
ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3
Current endocrine therapy for prostate cancer (PCa) mainly inhibits androgen/androgen receptor (AR) signaling. However, due to increased intratumoural androgen synthesis and AR variation, PCa progresses to castration-resistant prostate cancer (CRPC), which ultimately becomes resistant to endocrine t...
Autores principales: | Zhou, Lijie, Song, Zhengshuai, Hu, Junyi, Liu, Lilong, Hou, Yaxin, Zhang, Xiaoping, Yang, Xiong, Chen, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738848/ https://www.ncbi.nlm.nih.gov/pubmed/33391508 http://dx.doi.org/10.7150/thno.49384 |
Ejemplares similares
-
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1
por: Zhou, Lijie, et al.
Publicado: (2021) -
Phosphorylation of PLIN3 by AMPK promotes dispersion of lipid droplets during starvation
por: Zhu, Jianxi, et al.
Publicado: (2018) -
SLC39A8/Zinc Suppresses the Progression of Clear Cell Renal Cell Carcinoma
por: Liu, Lilong, et al.
Publicado: (2021) -
Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis
por: Hou, Yaxin, et al.
Publicado: (2021) -
An RDH‐Plin2 axis modulates lipid droplet size by antagonizing Bmm lipase
por: Zhao, Xuefan, et al.
Publicado: (2022)